Clinical trial
Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery…
NCT00178620 · The University of Texas Health Science Center, Houston, Other · Completed
Key facts
| NCT number | NCT00178620 |
|---|---|
| Title | Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization |
| Official title | PATCAR Pilot Trial: A Phase 4 Study, Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization |
| Acronym | PATCAR |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Disease, Myocardial Infarction, Acute Myocardial Infarction |
| Intervention type | Drug, Procedure |
| Interventions | Reteplase 10 Units (U) plus a second dose of reteplase 10 U, Reteplase 10 U, Urgent Percutaneous Coronary Intervention (PCI), Primary Percutaneous Coronary Intervention (PCI) |
| Enrollment | 390 |
| Start date | Sep 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 6, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: